Atlas Trials

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)

Clinical trial NCT00265824 · COMPLETED

Trial details

NCT number
NCT00265824
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2005-05-01
Primary completion
2012-03-01
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.